How do Alzheimer’s biomarkers change over time?
Biomarkers for the diagnosis of Alzheimer’s disease The characteristic symptoms of Alzheimer’s disease, such as progressive memory loss or other cognitive deficits and behavioral disorders, can make us suspect the diagnosis of this disease. This suspicion...
Super-resolution is here for amyloid plaques
Non-fibrillar amyloid-β (Aβ) plaques are considered to be a critical component of Alzheimer’s disease. Characterization of these species comes mainly from studies in cellular or animal models, but there is little data in intact human samples due to the lack of...
Links:
Educational sessions:
In our recent publication, we analyze cortical microstructure in frontotemporal dementia
The behavioral variant of frontotemporal dementia is a neurodegenerative syndrome characterized by a progressive personality change. Given that patients maintain their cognitive abilities relatively intact in the early stages of the disease, the diagnosis requires...
Ignacio Illán-Gala defends his doctoral thesis on frontotemporal degeneration
Today, Ignacio Illán-Gala has defended his Doctoral Thesis entitled “Pathophysiological and structural underpinnings of frontotemporal lobar degeneration: a multimodal biomarker study“, co-directed by Dr. Alberto Lleó and Dr. Juan Fortea. This exceptional...
III Symposium of the DEGESCO Consortium
On May 16th, the III Symposium of the DEGESCO Consortium on Dementia Genetics will be held in Málaga, in the context of the VI Málaga Alzheimer Conference, sponsored by CIBERNED and the Andalusian Institute of Neuroscience. During the DEGESCO symposium, the ongoing...
Roser Ribosa defends her doctoral thesis on music therapy and cognitive rehabilitation in Parkinson’s
Roser Ribosa has defended her doctoral thesis entitled “Non-pharmacological therapies in the rehabilitation of Parkinson’s disease: Comparison of music therapy and cognitive training” . This work has been directed by Dr. Javier Pagonabarraga and Dr....
Dr. Illán-Gala has been selected as an “Atlantic Fellow” in the GBHI program
Dr. Ignacio Illán-Gala has been selected as one of the “Atlantic Fellows” of the Global Brain Health Institute (GBHI) in 2019. The objective of this program, coordinated by the University of California San Francisco and Trinity College Dublin, is to...
Is obesity a risk factor for Alzheimer’s disease?
Obesity and Alzheimer It has been established that middle-age obesity is a risk factor for Alzheimer’s disease, but the results from studies in older people are contradictory. Our recent study would explain the discrepancies on this topic. This work is the...